Improvement of insulin sensitivity and dyslipidemia with a new α-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects☆
To access this article, please choose from the options below
☆ Supported by Special Coordination Funds for Promoting Science and Technology (Encouragement System of Center of Excellence) from the Science and Technology Agency of Japan, and by a grant for Scientific Research Expenses for Health and Welfare Programs (Clinical Treatment of Diabetes Mellitus, Akanuma).
PII: S0026-0495(96)90139-0
© 1996 Published by Elsevier Inc.
